Clearside Biomedical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.About CLSD
Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases.
CEOGeorge M. Lasezkay
CEOGeorge M. Lasezkay
Employees32
Employees32
HeadquartersAlpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded2011
Founded2011
Employees32
Employees32
CLSD Key Statistics
Market cap65.65M
Market cap65.65M
Price-Earnings ratio-2.12
Price-Earnings ratio-2.12
Dividend yield—
Dividend yield—
Average volume122.59K
Average volume122.59K
High today$0.90
High today$0.90
Low today$0.8212
Low today$0.8212
Open price$0.8692
Open price$0.8692
Volume369.66K
Volume369.66K
52 Week high$1.65
52 Week high$1.65
52 Week low$0.7001
52 Week low$0.7001
CLSD News
TipRanks 1h
Clearside Biomedical Reports Q1 2025 Financial ProgressClearside Biomedical Inc ( (CLSD) ) has released its Q1 earnings. Here is a breakdown of the information Clearside Biomedical Inc presented to its investors. C...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.